{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-248289","form_type":"8-K","ticker":"BNTC","cik":"0001808898","company_name":"Benitec Biopharma Inc.","filed_at":"2026-05-29T20:10:56+00:00","discovered_at":"2026-05-29T20:12:01.456946+00:00","generated_at":"2026-05-29T20:12:08.351904+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Benitec Biopharma appoints David Friedman to board; Megan Boston resigns as director but remains CFO","bullets":["David Friedman joined board as Class III director effective May 22, 2026; term until 2028 annual meeting.","Friedman granted options to purchase 35,000 shares at closing price on May 26, 2026; vesting by next annual meeting or 1 year.","Megan Boston resigned from board effective May 22, 2026; continues as CFO and secretary; no dispute.","Friedman entitled to standard non-employee director compensation; will enter indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248289","json":"https://secwatch.observer/filing/0001193125-26-248289.json","markdown":"https://secwatch.observer/filing/0001193125-26-248289.md","text":"https://secwatch.observer/filing/0001193125-26-248289.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/bntc-20260522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T20:12:08.351904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"46992999b3","claim":"Megan Boston resigned as Director at Benitec Biopharma Inc..","evidence_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","confidence":0.95},{"claim_id":"d65cc0a1f2","claim":"David Friedman was appointed as Director at Benitec Biopharma Inc..","evidence_excerpt":"On May 22, 2026, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed David Friedman to serve as a director of the Board, effective as of such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001850902-26-000011","ticker":"TKNO","company_name":"Alpha Teknova, Inc.","filed_at":"2026-06-01T21:22:10+00:00","headline":"Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor","event_type":"leadership","sec_items":["5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001850902-26-000011","json":"https://secwatch.observer/filing/0001850902-26-000011.json","markdown":"https://secwatch.observer/filing/0001850902-26-000011.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000185090226000011/0001850902-26-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000185090226000011/tkno-20260527.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1850902/000185090226000011/0001850902-26-000011-index.htm"}},{"accession":"0001213900-26-063573","ticker":"MZYX","company_name":"MOZAYYX Acquisition Corp.","filed_at":"2026-06-01T21:00:14+00:00","headline":"MOZAYYX Acquisition appoints Emma Rose Bienvenu as independent director","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063573","json":"https://secwatch.observer/filing/0001213900-26-063573.json","markdown":"https://secwatch.observer/filing/0001213900-26-063573.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2097376/000121390026063573/0001213900-26-063573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2097376/000121390026063573/ea0292919-8k_moxayyx.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"On May 26, 2026, the Board of Directors (the “ Board ”) of MOZAYYX Acquisition Corp. (the “ Company ”) appointed Emma Rose Bienvenu to serve as an independent director of the Company, effective immediately.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2097376/000121390026063573/0001213900-26-063573-index.htm"}},{"accession":"0001477932-26-003559","ticker":"JOB","company_name":"GEE Group Inc.","filed_at":"2026-06-01T20:47:44+00:00","headline":"Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-003559","json":"https://secwatch.observer/filing/0001477932-26-003559.json","markdown":"https://secwatch.observer/filing/0001477932-26-003559.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/40570/000147793226003559/0001477932-26-003559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/40570/000147793226003559/job_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/40570/000147793226003559/0001477932-26-003559-index.htm"}},{"accession":"0001534969-26-000028","ticker":"SERA","company_name":"SERA PROGNOSTICS, INC.","filed_at":"2026-06-01T20:44:21+00:00","headline":"Sera Prognostics director Jeff Elliott resigns ahead of annual meeting","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001534969-26-000028","json":"https://secwatch.observer/filing/0001534969-26-000028.json","markdown":"https://secwatch.observer/filing/0001534969-26-000028.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534969/000153496926000028/0001534969-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534969/000153496926000028/sera-20260526.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"Jeffrey T. Elliott, a member of the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of June 4, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496926000028/0001534969-26-000028-index.htm"}},{"accession":"0001681459-26-000035","ticker":"FTI","company_name":"TechnipFMC plc","filed_at":"2026-06-01T20:38:05+00:00","headline":"TechnipFMC appoints Eric D. Mullins to Board of Directors effective June 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001681459-26-000035","json":"https://secwatch.observer/filing/0001681459-26-000035.json","markdown":"https://secwatch.observer/filing/0001681459-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681459/000168145926000035/0001681459-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681459/000168145926000035/fti-20260529.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"the Board elected Eric Mullins to the Board and appointed Mr. Mullins to the Audit Committee of the Board, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1681459/000168145926000035/0001681459-26-000035-index.htm"}},{"accession":"0001193125-26-251548","ticker":"MCRB","company_name":"Seres Therapeutics, Inc.","filed_at":"2026-06-01T20:30:55+00:00","headline":"Seres Therapeutics board member Hans-Juergen Woerle resigns, effective May 31, 2026","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251548","json":"https://secwatch.observer/filing/0001193125-26-251548.json","markdown":"https://secwatch.observer/filing/0001193125-26-251548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609809/000119312526251548/0001193125-26-251548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609809/000119312526251548/d100982d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1609809/000119312526251548/0001193125-26-251548-index.htm"}},{"accession":"0000827054-26-000020","ticker":"MCHP","company_name":"MICROCHIP TECHNOLOGY INC","filed_at":"2026-06-01T20:18:43+00:00","headline":"Microchip appoints former SVP Mitch Little to board, effective June 1, 2026","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000827054-26-000020","json":"https://secwatch.observer/filing/0000827054-26-000020.json","markdown":"https://secwatch.observer/filing/0000827054-26-000020.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/827054/000082705426000020/0000827054-26-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/827054/000082705426000020/mchp-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"appointed Mitch Little, former Senior Vice President, Worldwide Client Engagement of Microchip, as a member of the Board, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/827054/000082705426000020/0000827054-26-000020-index.htm"}},{"accession":"0001680247-26-000091","ticker":"PUMP","company_name":"ProPetro Holding Corp.","filed_at":"2026-06-01T20:16:36+00:00","headline":"Director Alex Volkov resigns from ProPetro board after Pioneer (Exxon) sells all shares","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001680247-26-000091","json":"https://secwatch.observer/filing/0001680247-26-000091.json","markdown":"https://secwatch.observer/filing/0001680247-26-000091.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680247/000168024726000091/0001680247-26-000091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680247/000168024726000091/pump-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm","comparable_excerpt":"On May 28, 2026, ProPetro Holding Corp. (the “Company”) announced the resignation of Alex V. Volkov from the Company’s Board of Directors (the “Board”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1680247/000168024726000091/0001680247-26-000091-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}